Celldex Therapeutics Inc. Revenue 2009–2025
Celldex Therapeutics Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Celldex Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 15000, a 97.84% decrease year-over-year.
- Celldex Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 4.6 M, a 4.33% increase year-over-year.
- Celldex Therapeutics Inc. annual revenue for 2025 was 1.5 M, a 77.99% decrease from 2024.
- Celldex Therapeutics Inc. annual revenue for 2024 was 7.0 M, a 1.99% increase from 2023.
- Celldex Therapeutics Inc. annual revenue for 2023 was 6.9 M, a 192.02% increase from 2022.
- Celldex Therapeutics Inc. annual revenue for 2022 was 2.4 M.
Celldex Therapeutics Inc. (CLDX) — Frequently Asked Questions
Celldex Therapeutics Inc. (CLDX) is a publicly traded US company. It has a market capitalization of $1.95B. In fiscal 2025 it reported revenue of $2M and net income of -$259M. Explore CLDX's stock price, financial statements, earnings history, margins and key ratios below.
What is Celldex Therapeutics Inc.'s market cap?
Celldex Therapeutics Inc. (CLDX) has a market capitalization of $1.95B.
What is the CLDX stock price?
CLDX trades at $29.35 (-0.84% on the day).
How much revenue does Celldex Therapeutics Inc. make?
Celldex Therapeutics Inc. reported revenue of $2M in fiscal 2025.
Is CLDX profitable?
In fiscal 2025, Celldex Therapeutics Inc. reported net income of -$259M.